Vivian Rodolf

Vivian Rodolf has extensive work experience in the medical and clinical research field. Vivian began their career as an Ophthalmologist at an Ophthalmology Clinic from 2004 to 2009. Vivian then transitioned into the role of an Oncology Epidemiologist at the National Cancer Institute Cairo from 2007 to 2014. From 2014 to 2016, Vivian served as a Clinical Research Associate dedicated to Amgen at IQVIA. Vivian then worked as a Global/Regional Clinical Trial Manager dedicated to Amgen at DOCS from 2016 to 2020. Vivian continued their career as a Medical Monitoring Consultant to Merck at ExecuPharm from 2020 to 2021. Currently, they are working as a Senior Clinical Scientist Consultant to BMS at R&D Partners, starting in 2021. In 2022, they joined Geron Corporation as the Medical Director. Their expertise includes protocol development, study implementation, data review, and training.

Vivian Rodolf earned a Doctor of Medicine (MD) degree from Cairo University, where they studied medicine from 1998 to 2006. Following this, they completed an Ophthalmology Residency Program from 2006 to 2007, specializing in the field of Ophthalmology. Later, they pursued a Masters of Medicine in Oncology Epidemiology from the National Cancer Institute in Cairo, specializing in Oncology Epidemiology from 2007 to 2009.